Estimates Revisions Arcus Biosciences, Inc.
Stocks
RCUS
US03969F1093
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 27.37 USD | +2.74% |
|
-5.36% | +14.86% |
| 14/07 | Arcus Biosciences Insider Sold Shares Worth $2,031,919, According to a Recent SEC Filing | MT |
| 25/06 | Arcus Biosciences Insider Sold Shares Worth $877,501, According to a Recent SEC Filing | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| - | |||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- RCUS Stock
- Consensus Arcus Biosciences, Inc.
- Estimates Revisions
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
